Overview
Jose Conejo-Garcia’s research program focuses on understanding and targeting the mechanisms governing the balance between immunosuppression and protective immunity in the tumor microenvironment, with an emphasis on the crosstalk between innate (gamma/delta) and adaptive (alpha/beta) T cells, and B lymphocytes, including in Tertiary Lymphoid Structures. Discoveries for the Conejo-Garcia lab are also being translated in active clinical trials using CAR T cells to treat ovarian cancer patients.
Current Appointments & Affiliations
Professor in Integrative Immunobiology
·
2024 - Present
Integrative Immunobiology,
Basic Science Departments
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Supplemental Table 5 from Measurement of Ovarian Tumor Immune Profiles by Multiplex Immunohistochemistry: Implications for Epidemiologic Studies
Other · November 26, 2025 <p>Supplemental Table 5 shows beta binomial models, odds ratios and 95% confidence intervals for marker positivity in the tumor, by population characteristics</p> ... Full text CiteSupplemental Table 3 from Measurement of Ovarian Tumor Immune Profiles by Multiplex Immunohistochemistry: Implications for Epidemiologic Studies
Other · November 26, 2025 <p>Supplemental Table 3 shows case characteristics included on tissue microarrays in NHS and NHSII</p> ... Full text CiteSupplemental Table 4 from Measurement of Ovarian Tumor Immune Profiles by Multiplex Immunohistochemistry: Implications for Epidemiologic Studies
Other · November 26, 2025 <p>Supplemental Table 4 shows beta binomial models, odds ratios and 95% confidence intervals for marker positivity in the tumor, by tumor and participant characteristics</p> ... Full text CiteRecent Grants
Novel immunotherapies using optimized tumor cell-penetrating antibodies
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2025 - 2029McCain/Bayh Glioblastoma Consortium
Clinical TrialCo Investigator · Awarded by Department of Defense · 2025 - 2029Crosstalk between butyrophilins and gamma delta T cells in human cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2024 - 2029View All Grants
Education, Training & Certifications
University of Alcalá (Spain) ·
1998
MD./PhD.